According to Corbus Pharmaceuticals
's latest financial reports the company has -$6.91 M in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $-6.91 M | -120.93% |
2022-12-31 | $32.99 M | -52.26% |
2021-12-31 | $69.1 M | 52.64% |
2020-12-31 | $45.27 M | 635.27% |
2019-12-31 | $6.15 M | -77.63% |
2018-12-31 | $27.52 M | -52.37% |
2017-12-31 | $57.78 M | 547.85% |
2016-12-31 | $8.91 M | -0.73% |
2015-12-31 | $8.98 M | 53.26% |
2014-12-31 | $5.86 M | -428.78% |
2013-12-31 | $-1.79 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Viking Therapeutics
VKTX | $0.93 B | -13,625.41% | ๐บ๐ธ USA |
Vanda Pharmaceuticals VNDA | $0.54 B | -7,991.85% | ๐บ๐ธ USA |
Advaxis ADXS | -$24.42 M | 253.63% | ๐บ๐ธ USA |